<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04023461</url>
  </required_header>
  <id_info>
    <org_study_id>4471/16/137</org_study_id>
    <nct_id>NCT04023461</nct_id>
  </id_info>
  <brief_title>Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients</brief_title>
  <official_title>Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is a prospective, randomized and double-blind clinical trial involving an invasive
      technique for isolation of pulmonary veins (PVAC gold) in relation to clinical treatment
      during an one year of segment. The patients included have paroxysmal atrial fibrillation
      (aged 65 years and older) refractory to antiarrhythmic treatments that do not have structural
      and / or ischemic heart diseases. This trial employs quality of life scores prior to the
      study and during the sixth and twelfth month of the segment, electrocardiograms and holter of
      24 hours. The proposed imaging tests will be the transesophageal echocardiogram before each
      procedure. The cerebral MRI will be performed in the 24 h post invasive procedure and
      Angio-tomography of the pulmonary veins in the 6-month segment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 29, 2017</start_date>
  <completion_date type="Anticipated">January 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 28, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Life Assessment</measure>
    <time_frame>1 year after ablation</time_frame>
    <description>Quality of Life in Atrial Fibrillation Questionnaire Score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrence of atrial fibrillation</measure>
    <time_frame>1 year after ablation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of Asymptomatic Cerebral Embolism</measure>
    <time_frame>1 year of follow-up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Esophageal Ulcer</measure>
    <time_frame>1 year of follow-up</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Atrial Fibrillation Paroxysmal</condition>
  <condition>Cardiac Arrythmias</condition>
  <arm_group>
    <arm_group_label>Clinical Treatment Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Interventional Ablation Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PVAC GOLD catheter ablation</intervention_name>
    <description>Isolation of pulmonary veins using PVAC GOLD catheter.</description>
    <arm_group_label>Interventional Ablation Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for isolation of pulmonary veins

          -  Age &gt;= 65 years old

          -  Association with the following characteristics:

               1. Symptomatic Atrial Fibrillation;

               2. Sinusal Rhythm maintenance failure for at least 1 Antiarrythmic Drugs;

               3. Diagnosis of Atrial Fibrilation on resting eletrocardiogram and/or 24h Holter.

        Exclusion Criteria:

          -  Prior Atrial Fibrillation ablation;

          -  Atrial Fibrillation permanent and/or persistent;

          -  Left atrial size &gt; 55 mm;

          -  Mechanical prothetic mitral valve replacement;

          -  Presence of atrial thrombus;

          -  Cardiac invasive procedure &lt; 90 days;

          -  Cerebral embolism &lt; 6 months;

          -  Hypertrophic cardiomyopathy;

          -  Contraindications to antiocoagulation and cerebral MRI.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauricio I Scanavacca, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arrythmia Clinical Unit Director</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mauricio I Scanavacca, MD, PhD</last_name>
    <phone>+55112661-5341</phone>
    <email>mauricio.scanavacca@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luiz Claudio B Martins, MD</last_name>
    <phone>+5513974189969</phone>
    <email>lcardio@uol.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arrhythmia Clinical Unit - Instituto do Coração - HCFMUSP</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>05403010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauricio I Scanavacca, MD, PhD</last_name>
      <phone>+551126615341</phone>
      <email>mauricio.scanavacca@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Luiz Claudio B Martins, MD</last_name>
      <phone>+5513974189969</phone>
      <email>lcardio@uol.com.br</email>
    </contact_backup>
    <investigator>
      <last_name>Luiz Claudio B Martins, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristiano F Pisani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carina A Hardy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Muhieddine O Chokr, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sissy L de Melo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabio K Dorfman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mauricio I Scanavacca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francisco C Darrieux, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cesar J Grupi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luciana Sacilotto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Denise T Hachul, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tam C Hu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Savia C Bueno, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 15, 2019</study_first_submitted>
  <study_first_submitted_qc>July 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2019</study_first_posted>
  <last_update_submitted>July 18, 2019</last_update_submitted>
  <last_update_submitted_qc>July 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>Mauricio Ibrahim Scanavacca</investigator_full_name>
    <investigator_title>Arrhythmia Clinical Unit Director</investigator_title>
  </responsible_party>
  <keyword>Radiofrequency Ablation</keyword>
  <keyword>Atrial Fibrilation</keyword>
  <keyword>PVAC GOLD catheter</keyword>
  <keyword>Elderly patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

